Actively Recruiting
Evaluation of Untinted and Tinted Facial Sunscreens for Improving Dark Spots in Adults Over 8 Weeks
Led by Kenvue Brands LLC · Updated on 2026-07-01
152
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the effectiveness of two types of facial sunscreensuntinted and tintedin improving facial dark spots such as melasma, solar lentigines, and post-inflammatory hyperpigmentation. This study involves adult participants who will use the products under normal daily conditions for eight weeks to assess changes in hyperpigmentation. Participants will be assigned to one of four groups based on their skin condition and sunscreen type melasma with untinted sunscreen, melasma with tinted sunscreen, solar lentigo or post-inflammatory hyperpigmentation with untinted sunscreen, and the same conditions with tinted sunscreen. Participants will apply the assigned sunscreen to their face at least twice daily for 56 days. During the study, participants will undergo dermatological evaluations and instrumental measurements using devices like the Chroma Meter CR 400 and Visia-CR Facial Imaging Booth at baseline, 14 days, 28 days, and 56 days. Quality of life questionnaires and perception surveys will assess the impact of facial spots and product efficacy. Participants will also provide an emotional testimonial at the studys end. The total duration of participation is 8 weeks.
CONDITIONS
Brief Title
A Clinical Study to Evaluate the Efficacy in Improving Dark Spots After 8 Weeks of Use of Facial Sunscreens in Adult Participants
Research Team
K
Kenvue Global Clinical Operations
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here